Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for sedation in ESRF patients
NCT04839536Phase 4
Key facts
- Status
- Unknown
- Start
- Apr 2021
- Primary completion
- Mar 2022
- Sponsor
- Universiti Malaya
- Modality
- Small Molecules
- Drugs
- sevoflurane
- Conditions
- Procedural sedation (PS)
01
Overview
Phase 4, randomised, open-label trial of sevoflurane in Procedural sedation (PS), sponsored by Universiti Malaya. Primary endpoint: Change in mean arterial pressure from baseline. Status: unknown.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Dialysis-dependent ESRF patients (ASA II/III) undergoing brachiocephalic fistula repair, excluding those with malignant hyperthermia, propofol allergy, recent CVA, or significant heart/lung disease.
04
Endpoints
Primary
Change in mean arterial pressure from baseline
Beyond the preview
Go deeper on NCT04839536.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839536.